Published in Ann N Y Acad Sci on May 13, 1998
Progress in the treatment of myasthenia gravis. Ther Adv Neurol Disord (2008) 0.96
Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (2001) 0.95
Bickerstaff's encephalitis. BMJ Case Rep (2014) 0.85
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58
Botulinum toxin for palmar hyperhidrosis. Lancet (1997) 3.17
The dynamic chloride component of membrane current in Purkinje fibers. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 2.90
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23
Excitatory membrane current in heart muscle (Purkinje fibers). Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 2.15
The potassium component of membrane current in Purkinje fibers. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 2.14
Liquid filament switch for ultra-fast exchanges of solutions at excised patches of synaptic membrane of crayfish muscle. Neurosci Lett (1987) 2.13
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 2.12
A role for BDNF in mechanosensation. Nat Neurosci (1998) 2.08
Voltage and time dependence of excitatory sodium current in cooled sheep Purkinje fibres. Pflugers Arch (1970) 1.97
The effect of tetrodotoxin on the membrane current in cardiac muscle (Purkinje fibers). Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 1.95
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Myasthenia gravis: passive transfer from man to mouse. Science (1975) 1.90
Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol (1998) 1.83
Nonlinear voltage dependence of excitatory synaptic current in crayfish muscle. Pflugers Arch (1974) 1.82
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler (2002) 1.80
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2000) 1.77
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler (2001) 1.76
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A (1996) 1.68
Prednisone in Duchenne muscular dystrophy. Lancet (1974) 1.65
Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature (1984) 1.63
Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet (1995) 1.60
Linkage of proximal myotonic myopathy to chromosome 3q. Neurology (1999) 1.60
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann Neurol (1998) 1.60
Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler (2006) 1.60
The effect of reduced calcium on quantal unit current and release at the crayfish neuromuscular junction. Pflugers Arch (1981) 1.55
Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology (1983) 1.53
Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med (2000) 1.52
[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]. Nervenarzt (2002) 1.50
Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve (2000) 1.50
Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today (2000) 1.49
Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve (2002) 1.47
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol (2008) 1.46
Activation kinetics and single channel properties of recombinant alpha1beta2gamma2L GABA(A) receptor channels. Neuroreport (1997) 1.41
A molecular scheme for the reaction between acetylcholine and nicotinic channels. Biophys J (1993) 1.41
Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation. Neuron (1996) 1.36
Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol (1986) 1.34
Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet (1995) 1.33
Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst (2001) 1.32
Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res (2001) 1.32
Neurotransmitter release and its facilitation in crayfish. I. Saturation kinetics of release, and of entry and removal of calcium. Pflugers Arch (1982) 1.29
Activation of rat recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin. Eur J Pharmacol (2000) 1.25
Single channel currents at six microsecond resolution elicited by acetylcholine in mouse myoballs. J Physiol (1998) 1.25
Kinetic constants of the acetylcholine (ACh) receptor reaction deduced from the rise in open probability after steps in ACh concentration. Biophys J (1991) 1.24
Single glutamate-gated synaptic channels at the crayfish neuromuscular junction. II. Dependence of channel open time on glutamate concentration. Pflugers Arch (1987) 1.23
Voltage dependence of amplitude and time course of inhibitory synaptic current in crayfish muscle. Pflugers Arch (1977) 1.22
Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci (1997) 1.22
Aspartate and other inhibitors of excitatory synaptic transmission in crayfish muscle. Pflugers Arch (1977) 1.22
Kinetics of homomeric GluR6 glutamate receptor channels. Biophys J (1996) 1.21
Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol (2001) 1.18
Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres. Nature (1967) 1.17
Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol (1983) 1.16
Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology (1996) 1.15
Meningeal hyperperfusion visualized by MRI in a patient with visual hallucinations and migraine. Headache (1996) 1.15
Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J Clin Invest (1999) 1.14
Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res (1993) 1.13
Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci (1996) 1.12
Autoreceptors, membrane potential and the regulation of transmitter release. Trends Neurosci (2000) 1.11
High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol (2001) 1.10
Potentiation and desensitization after glutamate induced postsynaptic currents at the crayfish neuromuscular junction. Pflugers Arch (1975) 1.09
Neurotransmitter release and its facilitation in crayfish. VII. Another voltage dependent process beside Ca entry controls the time course of phasic release. Pflugers Arch (1986) 1.09
Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett (1999) 1.09
Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol (2006) 1.08
Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci (1995) 1.08
[Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations]. Nervenarzt (2001) 1.08
Inhibitory synaptic channels activated by gamma-aminobutyric acid (GABA) in crayfish muscle. Pflugers Arch (1980) 1.08
Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol (1992) 1.08
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol (1991) 1.06
T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology (1990) 1.06
Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci (1997) 1.06
Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain (2003) 1.05
Activation and desensitization of embryonic-like receptor channels in mouse muscle by acetylcholine concentration steps. J Physiol (1992) 1.04
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology (2012) 1.04
Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit. Proc Natl Acad Sci U S A (1987) 1.04
Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology (1986) 1.04
Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci (2000) 1.03
Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II. Muscle Nerve (1995) 1.03
Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain (2001) 1.02
Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol (2001) 1.02
The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol (2001) 1.02
Relaxation after a voltage step of inhibitory synaptic current elicited by nerve stimulation (crayfish neuromuscular junction). Pflugers Arch (1978) 1.02
["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]. Nervenarzt (2006) 1.02
Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology (2003) 1.02
The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system. Acta Neuropathol (1985) 1.01
Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol (1998) 1.01
Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol (1993) 1.01
Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. Muscle Nerve (1995) 1.01
Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations. Muscle Nerve (1996) 1.00
Neurotransmitter release and its facilitation in crayfish muscle. VI. Release determined by both, intracellular calcium concentration and depolarization of the nerve terminal. Pflugers Arch (1983) 1.00
Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev (2005) 0.99
MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol (1996) 0.99
Control of quantal transmitter release at frog's motor nerve terminals. II. Modulation by de- or hyperpolarizing pulses. Pflugers Arch (1984) 0.99